Startup
Hemab Therapeutics
Startup · Copenhagen, Denmark
Hemab is a clinical-stage biotech company developing prophylactic therapies for severe bleeding and thrombotic disorders. Founded by biotech operators with Novo Nordisk roots, the company engineers antibody-based treatments aimed at preventing episodes before they occur in underserved rare-disease populations.
Connection map
Affiliation
Drag nodes to rearrange · scroll or pinch to zoom · click a node to open it